Immunologic reaction to insulin and other proteins

Leslie C Grammer III*

*Corresponding author for this work

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Immunologic reactions have been known to occur in response to pharmacologic administration of nonhuman and human recombinant proteins. IgE-mediated type I hypersensitivity is the most common, but type III immune complex disease has also been described. Other immunologic reactions such as induction of anti-protein antibody and resultant inactivation of protein have also been described. Hypersensitivity reactions to recombinant human proteins are most likely caused by alterations in tertiary protein structure because the primary amino acid sequence of rDNA proteins is identical to the endogenously produced human proteins. Skin testing and desensitization protocols have been reported for many protein pharmacologic agents. As more pharmacologic, recombinant human proteins become available, they will likely cause similar immunologic reactions.

Original languageEnglish (US)
Pages (from-to)809-816
Number of pages8
JournalImmunology and Allergy Clinics of North America
Volume18
Issue number4
DOIs
StatePublished - Jan 1 1998

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Immunologic reaction to insulin and other proteins'. Together they form a unique fingerprint.

  • Cite this